SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $272,000 | -51.7% | 13,036 | -45.0% | 0.00% | -50.0% |
| Q2 2020 | $563,000 | +31.9% | 23,694 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $427,000 | -31.8% | 23,694 | -10.2% | 0.01% | +16.7% |
| Q4 2019 | $626,000 | -13.8% | 26,394 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $726,000 | -16.9% | 26,394 | 0.0% | 0.01% | -11.1% |
| Q2 2019 | $874,000 | -5.5% | 26,394 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $925,000 | +5.5% | 26,394 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $877,000 | -34.0% | 26,394 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $1,329,000 | -15.9% | 26,394 | 0.0% | 0.01% | -18.8% |
| Q2 2018 | $1,580,000 | +48.1% | 26,394 | +13.3% | 0.02% | +45.5% |
| Q1 2018 | $1,067,000 | +15.0% | 23,287 | +0.0% | 0.01% | +22.2% |
| Q4 2017 | $928,000 | 0.0% | 23,277 | +0.3% | 0.01% | +12.5% |
| Q3 2017 | $928,000 | -7.2% | 23,204 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $1,000,000 | +240.1% | 23,204 | +20.2% | 0.01% | +200.0% |
| Q1 2016 | $294,000 | +20.0% | 19,300 | +6.0% | 0.00% | +50.0% |
| Q4 2015 | $245,000 | – | 18,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |